CPC A61K 31/551 (2013.01) [A61K 31/137 (2013.01); A61K 31/5415 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); G01N 33/57415 (2013.01)] | 20 Claims |
1. A method for treating a cancer, the method comprising:
administering to a subject in need thereof a bromodomain and extra terminal (BET) inhibitor and a protein phosphatase 2A (PP2A) activator in an amount effective to treat the cancer, wherein the cancer is resistant to treatment by the BET inhibitor alone.
|